Global Outlook for Wearable Medical Devices Market By Key Trends and Analysis 2023

The last decade has witnessed growing interest in wearable medical devices. Currently technology is combined with medicine and frequently explains how patients are diagnosed and treated. The medical devices are leader of numerous success stories. Wearable medical devices that monitor, control, track, and treat patient conditions are increasingly replacing larger equipment. Wearable medical devices are connected to a patient’s body and measure clinically appropriate information. These devices resemble eyeglasses, watch, clothing, jewelry, contact lenses, etc. Data collected from wearable medical devices can be as simple as number of steps taken in a day to complex data such as ECG measurement. This report on the global market studies the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. This section also provides the overall information and data analysis of the global market with respect to the leading market segments based on type of device, application, and geography.

Obtain Report Details @
http://www.transparencymarketresearch.com/wearable-medical-devices.html

The market overview section of the report includes qualitative analysis of the overall market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces Analysis, list of FDA-approved wearable medical devices and value chain analysis. In addition, various analyses such as market attractiveness analysis by type of device and competitive landscape by key players have been provided. The market attractiveness analysis explains the intensity of competition in the market in different types of devices. The competitive scenario between market players is evaluated through market share analysis. These factors would help market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.

The global wearable medical devices market has been segmented based on type of device, application, and geography. Based on type of device, the market has been categorized into two major segments: diagnostic and therapeutic. Diagnostic devices have been further classified into heart rate monitors, activity monitors, sleep monitor, electrocardiograph, fetal monitor and obstetric devices, and neuromonitoring devices. Therapeutic devices have been classified into vital sign monitors, pain management devices, glucose insulin monitoring devices, and respiratory therapy devices. Based on application, the global market has been segmented into three types: sports and fitness, remote patient monitoring, and home health care. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all the segments, considering 2014 as the base year.

Geographically, the wearable medical devices market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, Japan, and Rest of Asia-Pacific. Rest of World comprises of Latin America, the Middle East, and Africa. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Cleveland Medical Devices, Inc., Corventis, Inc. (Medtronic plc.), Fitbit, Inc., Intelesens Ltd., Koninklijke Philips N.V., LifeWatch AG, Nuubo, OMRON Corporation, Polar Electro, and Zephyr Performance Systems (Medtronic plc.).

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1733

About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Advertisements

Active Pharmaceutical Ingredients (API) Market Global Industry Volume By Region 2015 – 2023

Climbing Numbers of Chronic Conditions Drive API Market

The growing pool of geriatrics is driving the demand for various types of drugs, which in turn is leading to a soaring demand of active pharmaceutical ingredient (API) market. Active pharmaceutical ingredients are primarily used for making drugs that are used for treating a range of chronic conditions such as cancer, metabolic disorders, cardiovascular diseases, neurology disorders as well as for other therapeutic uses. Given this strong background, Transparency Market research states the opportunity in this market will be worth US$219.60 bn by 2023 from US$134.7 bn in 2015. Between the forecast period of 2015 and 2023, the overall market is expected to expand at a CAGR of 6.3%.

The improving access to healthcare with the rapid penetration of technology and other developments in the healthcare sector has also increased the consumption of drugs, thereby directly creating a positive impact on this market. Furthermore, growing healthcare budgets of developed and developing countries are also making a significant contribution towards propelling the sale of API market. Furthermore, the compliance by Indian active pharmaceutical ingredients manufacturers with U.S. FDA norms is also anticipated to result in increasing applications of this substance.

Obtain Report Details @
http://www.transparencymarketresearch.com/active-pharmaceutical-ingredients.html

Complicated Cardiovascular Diseases to Keep Fueling Demand for APIs

As of 2015, the high incidence of cardiovascular diseases, neurological disorders, and other metabolic disorders led these therapeutic segments to account for a collective share of 50% in the global market. In the forecast period, the prevalence of complicated cardiovascular conditions is going to propel this therapeutic area at a 6.63% CAGR. Furthermore, as the majority of the blockbuster drugs lost patents between 2011 and 2015, it has opened a huge ground for other companies to introduce their drugs, thereby increasing the competition and probably reducing costs.

Asia Pacific to Emerge as Key Manufacturer of APIs

As of 2014, North America held a dominant share in the overall market, accounting for about 35.1% share in the market. The presence of big pharmaceutical companies in North America that require large amounts of active pharmaceutical ingredients is the major factor driving the API market in North America. Analysts predict that introduction of biosimilars as the regulatory process get relaxed will further accelerate the consumption of active pharmaceutical ingredients in North America. The API manufacturing will experience an upsurge in the emerging economies of Japan, China, South Korea, and India due to the presence of manufacturing facilities and cheap cost of labor.

Some of the leading companies operating in the global active pharmaceutical ingredient market are Zhejiang Medicine Co., Ltd., Teva Pharmaceutical Industries Ltd., Zhejiang NHU Co., Ltd , North China Pharmaceutical Group Corp. (NCPC), Dr.Reddy’s Laboratories Limited, Northeast Pharmaceutical Group Co., Ltd., Aurobindo Pharma Limited, Sandoz (Novartis AG), Zhejiang Hisun Pharmaceutical Co., Ltd. and Zhejiang Huahai Pharmaceuticals Co., Ltd. amongst others. Currently, these players are focusing on partnering with other companies to acquire a new line of products to add value to their portfolio. Furthermore, companies are also anticipated to focus on expanding their capacities to cater to the vast unmet medical needs of the world.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1690

About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Gynecological Devices Market – Global Industry Analysis and Forecast 2015 – 2023

The global market for gynecological devices features a highly fragmented vendor landscape, with the leading three companies, namely Olympus Corporation, Boston Scientific Corporation, and Cooper Surgical accounted for over 25.5% of the market’s overall revenue in 2014, observes Transparency Market Research in a recent report. Although regional players and new vendors account for a significant share in the market’s revenue presently, entry barriers are becoming more intense for new companies. Increasingly stringent, slow, and expensive regulatory approval procedures are increasing operational challenges for companies in the market.

Furthermore, the lack of venture capitalists willing to fund companies in the gynecological devices sector has made matters worse for new companies in the market. Nevertheless, the market offers vast growth opportunities in the form of the rising demand for innovative products and the increasing adoption of noninvasive devices across the globe. Moreover, with the rise in the number of patients opting for regular check-ups, especially across developing economies, is also expected to create a vast set of opportunities for vendors in the global gynecological devices market.

Transparency Market Research estimates that the global gynecological devices market will exhibit a healthy CAGR of 4.8% over the period between 2015 and 2023 and rise from a valuation of US$14.9 bn in 2014 to US$22.5 bn by 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/gynecological-devices-market.html

North America to Continue to Account for Dominant Share in Global Market Revenue

In terms of device type, the segment of gynecological surgical devices held the dominant share in the global gynecological devices market in 2014 and is expected to retain its dominance over the report’s forecast period as well. The segment is projected to exhibit a 4.4% CAGR over the report’s forecast period. Geographically, the market in North America is presently leading the global gynecological devices market. Driven due to the vast growth opportunities provided by the U.S. and Canada and the presence of a large number of companies, the North America market for gynecological devices held a nearly 41.1% of the overall market in 2014 and is expected to retain dominance over the report’s forecast period as well.

Increased Preference to Minimally Invasive Gynecology Devices to Drive Global Market

Some of the key factors driving the global market for gynecological devices are the rising prevalence of a number of gynecological disorders, the increased adoption of noninvasive or minimally invasive gynecological procedures, and the increase in healthcare expenditure across emerging economies. Owing to the presence of a large number of companies and the intense level of competition in the market, focus on R&D activities and the increased energy directed towards the introduction of innovative devices are leading to the development of highly advanced and reliable noninvasive devices for the gynecological devices sector.

Increase in healthcare expenditure, especially across emerging economies in regions such as Asia Pacific and Latin America, is also providing significant boost to the overall demand for gynecological devices in the region. Continued efforts aimed at the improvement of the healthcare infrastructure in these regions will also boost the demand for advanced gynecological devices in the near future.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=613

About Us   

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Outlook for Parenteral Nutrition Market By Key Trends and Analysis 2023

The progress of the global parenteral nutrition market is based on the high prevalence of chronic conditions across the globe. The rise in cancer, AIDS, diabetes, Crohn’s disease, gastro-intestinal disorders, and short bowel syndrome cases has also led a growth in the consumption of parenteral nutrition in the recent years. The World Health Organization (WHO) affirmed this fact with statistics indicating that there will be a 70% rise in the number of new cancer cases between 2025 and 2035. The Crohn’s & Colitis Foundation of America also provided grim figures indicating that there will be 70,000 new cases of Crohn’s disease each year. Thus, the rising health complications will propel the demand for parenteral nutrition across health facilities.

These supportive factors are expected to create an opportunity for this market, which will be worth US$6.9 bn by 2023 as compared to US$4.1 bn in 2014. Between the years 2015 and 2023, this market is expected to expand at a CAGR of 5.7%.

Obtain Report Details @
http://www.transparencymarketresearch.com/parenteral-nutrition-market.html

North America Accounted for Over 40% of the Parenteral Nutrition Market in 2014

North America was the leading geographical segment in the global parenteral nutrition market as of 2014, accounting for nearly 40.1% share. The high rate of approvals from the U.S. FDA and supportive insurance policies that cover expenditure on parenteral nutrition are expected to keep this region in the leading position during the forecast period. The North America parenteral nutrition market that comprises the U.S. and Canada will also be driven by rising number diabetes and cancer cases. Furthermore, companies are also trying to expand their operations in Canada to gain a stronger foothold by meeting the unmet needs of the patients.

Meanwhile, the parenteral nutrition market in Asia Pacific is expected to surge at the highest pace of 7.3% CAGR between 2015 and 2023. The emerging economies and developing pharmaceutical markets of countries such as China, India, Indonesia, Singapore, Taiwan, and Thailand amongst others are expected to encourage the growth of this market within Asia Pacific. The rising cases of preterm birth, which leads to malnutrition is the prime reason for rising consumption of parenteral nutrition in Asia Pacific.

Single Dose Amino Acid Solutions Nutrients is Most Attractive Product Segment

Out of all the products available in the global parenteral nutrition market, the single dose amino acid solutions nutrient segment captured a significant share of 34.14% in 2014. Research indicates that this segment will be the leading nutrient segment as several leading players are introducing unique amino acid-based PN products. The abundant availability of these products is expected to be the main reason for their soaring success in the forecast period. Reports also suggest that the parenteral lipid emulsion nutrient segment will grow at the highest CAGR of 6.2% amongst all other nutrient segments between 2015 and 2023.

The leading players shaping the vendor landscape of the global parenteral nutrition market are Sichuan Kelun Pharmaceutical Co., Ltd., Allergan plc (Actavis plc), Fresenius SE & Co. KGaA, Grifols S.A., Baxter International, Inc., Claris Lifesciences Limited, and B. Braun Melsungen AG, Pfizer, Inc. (Hospira, Inc.) amongst others. Companies are trying to seek approvals for their new parenteral nutrition formulations from concerned authorities such as the U.S. FDA to launch new products in the market. This effort is focused at both grabbing new market shares and providing for the deficit of parental nutrition in developing regions.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3611

About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Outlook for Cardiac Pacemaker Market By Key Trends and Analysis 2023

Global Cardiac Pacemaker Market: Snapshot

By 2030, nearly 20% of the total U.S. population is expected to be made up of geriatrics, according to the U.S. Census Board. This is a huge growth in the number of elderly citizens in this country, and similar cases are being witnessed in most developed economies and a few developing ones as well. This rise in the geriatric population is expected to be the greatest driver for a lot of healthcare industry segments, including the market of cardiac pacemakers.

At the same time, the number of patients with heart complications is increasing significantly due to inculcation of modern lifestyles that can lead to obesity and high stress. Both factors are primarily responsible for the increasing demand for cardiac pacemakers among those younger than 65 years.

However, manufacturers of cardiac pacemakers also have to face problems such as the complex and time consuming approval procedure for sales of cardiac pacemakers due to their high risk nature of use. Additionally, players also have to significantly reduce their profit margins due to the implementation of policies such as the Affordable Healthcare Act in the U.S.

As a result of the given factors, the global revenue generated from cardiac pacemakers is expected to reach US$12.8 bn by the end of 2023, according to Transparency Market Research. In terms of volume, the total number of cardiac pacemakers consumed globally will cross 2.4 mn units.cardiac-pacemaker-market”

Obtain Report Details @
http://www.transparencymarketresearch.com/cardiac-pacemakers-market.html

Asia Pacific Shows High Growth Scope in Cardiac Pacemaker Demand

Based on the current trends in cardiac pacemaker supply and demand chains, Asia Pacific is expected to show the fastest growth rate, ending up with a share in volume of 20.3% by the end of 2023. The key factors responsible for the growth in cardiac pacemaker sales in this region include the growth in awareness of modern pacemakers and the increasing number of heart disease patients across the region.

Europe, however, is expected to retain its leading position for the number of cardiac pacemakers consumed. This region is expected to hold a volume share of 51.1% in 2023 due to a high percentage of the elderly and other heart disease patients. In terms of revenue, North America leads the global market for cardiac pacemakers.

Implantable Pacemakers Most Preferred Type Globally

Almost all of the cardiac pacemakers used in the world today are implantable as there are very few cases where external cardiac pacemakers would be required. Most patients with heart problems require implantable pacemakers. This segment is also expected to show the fastest growth rate for the coming few years due to a high global demand for advanced implantable cardiac pacemakers. The total revenue generated through implantable cardiac pacemakers is expected to reach US$12.5 bn by the end of 2023.

Most of the heart problem indicators point to the need for a permanent pacemaker. These include a complete atrio-ventricular blockage, symptomatic sinus bradycardia, and sick sinus syndrome. Sick sinus syndrome is additionally the most common illness faced by European patients in need of cardiac pacemakers.

The key companies in the cardiac pacemakers market include Medtronic, St. Jude Medical, Boston Scientific, Biotronik, and Sorin. A very small share of the cardiac pacemakers market is taken up by regional players, as the above leader constitute most of the global supply currently.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=393

About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

ePharmacy Market – Global Industry Analysis and Forecast 2015 – 2023

Transparency Market Research has published a new report on the global epharmacy market. As per the report, the global epharmacy market is expected to expand at a 17.50% CAGR during the period from 2015 to 2023. The report, titled ‘ePharmacy Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,’ states that the epharmacy market is expected to progress from US$29.35 bn in 2014 to US$128.02 bn by 2023 due to factors such as the need for convenient access to required medication and the rising aging population.

Internet pharmacy or epharmacy is an online platform, which acts as an intermediate between the seller and consumer for the sale of medicines. ePharmacies are gaining popularity across the globe owing to the many benefits they offer, including easy access to complete information on prescribed drugs, low or discounted drug prices, and round-the-clock delivery of drugs. It is not necessary for the patients to be physically present at a store to buy required medicines, making ePharmacies a convenient option. The ePharmacies market is expected to grow rapidly due to the development of government regulations and ethical practices.

Obtain Report Details @
http://www.transparencymarketresearch.com/epharmacies-market.html

ePharmacies serve many needs such as easy access to medical records and easy availability of medicines in remote areas. Thanks to the development of ePharmacies, consumers can easily procure drugs via a tablet or smartphones. ePharmacies are a boon for patients who are seriously ill and need medicines urgently. However, the rising illegal sale of controlled prescription drugs is expected to hamper the growth of the global ePharmacy market in the years to come. Sales of medicines through ePharmacies can also lead to incidents of self-medication or drug abuse, which can be avoided with the integration of advanced technologies associated with drug delivery procedures.

Based on geography, the global epharmacy market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East. In 2014, in terms of revenue, the global epharmacy market was dominated by North America, followed by Europe. Europe is expected to be the fastest growing market in the global epharmacy market by 2023 due to factors such as the increasing penetration of high-speed internet and the increasing preference for buying medicines online. In the next few years, Asia Pacific is predicted to display lucrative growth due to the increasing spread of the e-commerce industry.

Some of the key players operating in the global epharmacy market are CanDrugstore.com, Lloyds Pharmacy Ltd., Domzdrowia.pl SA, Walgreen Co., Rowlands Pharmacy, CVS Caremark, PlanetRx.com, drugstore.com Inc., The SANICARE Group, eDrugstore.MD, and CanadaDrugs.com. The entry of new ePharmacies is expected to make the global ePharmacy market highly competitive in the years to come.

From essentials to luxury products, everything is available on the internet via various retail platforms. The healthcare and medical sector are no exception. Over the past few years, there has been an increase in the number of people depending on online retail stores for their medicines. The increasing pool of people buying medicines from renowned epharmacies is expected to thus propel the global epharmacy market in the years to come.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=397

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Spinal Trauma Devices Market Global Industry Volume By Region 2015 – 2023

Global Spinal Trauma Devices Market Insights 

The rising awareness about the recent medical advances among patients will strengthen the position of spinal trauma devices manufacturers in the global market. As per Transparency Market Research (TMR), the paradigm shift from metallic fixators to bioresorbable implants will fuel demand from the global spinal trauma devices market. The market is also likely to gain impetus from the rising demand for minimally invasive surgeries.

Despite witnessing favorable growth opportunities, the lack of proper insurance facilities may limit the market’s expansion across developing economies. Nevertheless, the presence of high unmet medical demands in these countries will provide lucrative opportunities for the spinal trauma devices manufacturers.

TMR says that the global spinal trauma devices market stood at US$2.8 bn in 2014. Rising at a CAGR of 5.6%, the market is expected to reach US$4.7 bn by the end of 2023.

Obtain Report Details @
http://www.transparencymarketresearch.com/spinal-trauma-devices-market.html

Better Efficiency offered by Internal Fixation Devices Fuels their Demand Considerably

Based on type, the global spinal trauma devices market is bifurcated into external fixation devices and internal fixation devices. Of these, the internal fixation devices segment is expected to dominate the market, and is expected to have the highest CAGR of 6.1% between 2015 and 2023. During the same forecast period the external fixation devices market is expected to expand at a CAGR of 4.7%.

Internal fixation devices have emerged as inexpensive and efficient methods of treating spinal injuries. In the last couple of years, the demand for internal fixation devices has surpassed that of external fixation devices because the former offers better flexibility, durability, and requires comparatively lesser post-operative follow-ups than the latter. The internal fixation devices segment can be further classified into bone grafts, rods and pins, and plate and screws. Of these, plate and screws held the largest share in the internal fixation segment in 2014. In the same year the plate and screws segment was valued at US$1.05 bn.

The external fixation devices segment includes spinal stimulators, braces, exoskeletons, Ilizarov devices, halo vests, and collars. Certain risks associated with external fixation devices such as redness, swelling, pain in the operated, and tightening of the skin, will limit the growth of the segment to an extent.

U.S. and Canada Hold High-value Opportunities for Spinal Trauma Devices

North America leads the global spinal trauma devices market. It held a share of 47% in the overall market in 2014. The U.S. and Canada have been exhibiting the most lucrative prospects for the spinal trauma devices market in North America. The rising reports of road accidents leading to spinal injuries and the introduction of the latest technologies in the medical industry are crucial factors fuelling demand for spinal trauma devices in North America.

The regional market is also significantly gaining from the increasing geriatric population and the surging adoption of premium-priced bioresorbable devices. The North America spinal trauma devices market is projected to expand at a CAGR of 5.1% between 2015 and 2023.

Asia Pacific, according to TMR, will exhibit the highest CAGR of 7.1% during the forecast period. The emerging nations in Asia Pacific exhibit immense potential due to the increasing prevalence of spinal disorders, rising geriatric population, favorable government policies, and the increasing healthcare expenditure.

Some of the leading companies operating in the global spinal trauma devices market are Stryker Corp., CONMED Corp., Medtronic, Smith & Nephew plc, NuVasive Inc., DePuy Synthes, Spinal Technology Inc., Arthrex Inc., ReWalk Robotics, Orthofix International NV, and others.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7613

About Us 

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/